Last updated on April 2016

An Open-Label Study of Dupilumab In Patients with Atopic Dermatitis Who Participated in Previous Dupilumab Clinical Trials


Brief description of study

An Open-Label Study of Dupilumab In Patients with Atopic Dermatitis Who Participated in Previous Dupilumab Clinical Trials

Detailed Study Description

The study doctor and Regeneron are conducting this research study of an investigational drug called dupilumab. The main purpose of this study is to collect long term safety data on adult subjects with moderate-to-severe atopic dermatitis who have previously been administered dupilumab.

Clinical Study Identifier: TX143375

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.